Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
Chia-Chi Lin(National Taiwan University Hospital), Yeong‐Shiau Pu(National Taiwan University Hospital), Ann‐Lii Cheng(National Taiwan University), Jason Chia‐Hsien Cheng(Koo Foundation Sun Yat-Sen Cancer Center), Chao‐Yuan Huang(Chung Shan Medical University), Yu‐Chieh Tsai(Chang Bing Show Chwan Memorial Hospital), Chih‐Hung Hsu(National Taiwan University of Science and Technology), Kuo‐How Huang(National Taiwan University), Feng‐Ming Hsu(National Taiwan University)
International Journal of Radiation Oncology*Biology*Physics
March 23, 2009
Cited by 34
Related Papers
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k